SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-22-004502
Filing Date
2022-03-01
Accepted
2022-03-01 17:42:09
Documents
4
Effectiveness Date
2022-03-01
Reference 429
333-254725

Document Format Files

Seq Description Document Type Size
1 S-8 nltx-2022x3x1xsx8.htm S-8 98164
2 EX-FILING FEES neoleukin-ex107filingfeeta.htm EX-FILING FEES 15899
3 EX-5.1 exhibit51-opinionoffenwick.htm EX-5.1 15190
4 EX-23.1 deloittetouchellp-sx8conse.htm EX-23.1 2075
  Complete submission text file 0001628280-22-004502.txt   132772
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263190 | Film No.: 22700018
SIC: 2834 Pharmaceutical Preparations